Genome-wide CRISPR Screens in Primary Human T Cells Reveal Key Regulators of Immune Function

Shifrut, Eric, Carnevale, Julia, Tobin, Victoria, Roth, Theodore L., Woo, Jonathan M., Bui, Christina T., Li, P. Jonathan, Diolaiti, Morgan E. +2 more·2018·Cell

DOI 10.1016/j.cell.2018.10.024

Cited by (565)

Items 301–400 of 565

Metabolic dialogues: regulators of chimeric antigen receptor T cell function in the tumor microenvironment
Josquin Moraly, Taisuke Kondo, Mehdi Benzaoui, Justyn DuSold, Sohan Talluri, Marie Pouzolles, Christopher Daniel Chien, Valérie Dardalhon, Naomi N. Taylor · 2024 · Molecular Oncology
PerturbDB for unraveling gene functions and regulatory networks
Bing Yang, Man Zhang, Yanmei Shi, Bing-Qi Zheng, Chuanping Shi, Daning Lu, Zhi-Zhi Yang, Yi-Ming Dong, Liwen Zhu, Xingyu Ma et al. · 2024 · Nucleic Acids Research
From variants to mechanisms: Neurogenomics in the post-GWAS era
Michael P. Margolis, Miao Tang, Miriam Gagliardi, Cindy H. Wen, Yeda Wu, Naomi R. Wray, Michael J. Ziller, Michael J. Gandal · 2025 · Neuron
E3 Ubiquitin Ligases as Immunotherapeutic Target in Atherosclerotic Cardiovascular Disease
Kikkie Poels, Winnie G. Vos, Esther Lutgens, Tom T. P. Seijkens · 2020 · Frontiers in Cardiovascular Medicine
Understanding neural development and diseases using CRISPR screens in human pluripotent stem cell-derived cultures
Mai Essam Ahmed, Julien Muffat, Yun Li · 2023 · Frontiers in Cell and Developmental Biology
Complementary CRISPR screen highlights the contrasting role of membrane-bound and soluble ICAM-1 in regulating antigen-specific tumor cell killing by cytotoxic T cells
Ann-Kathrin Mattes, Marta Puig Gámez, Eva Martin, Łukasz M. Boryń, Praveen Baskaran, Heinrich J. Huber, Michael J. Schuler, John Edward Park, Lee Kim Swee · 2023 · eLife
Gene editing: Towards the third generation of adoptive T-cell transfer therapies
Cristina Puig-Saus, Antoni Ribas · 2019 · Immuno-Oncology Technology
Genome-wide CRISPR screens for the identification of therapeutic targets for cancer treatment
Vivian Weiwen Xue, Sze Chuen Cesar Wong, William Chi Shing Cho · 2020 · Expert Opinion on Therapeutic Targets
Combination of CRISPR/Cas9 System and CAR-T Cell Therapy: A New Era for Refractory and Relapsed Hematological Malignancies
Kejia Hu, Elaine Tan Su Yin, Yongxian Hu, He Huang · 2021 · Current Medical Science
CRISPR/Cas-based Human T cell Engineering: Basic Research and Clinical Application
Bettina E. Bernard, Emmanuelle Landmann, Lukas T. Jeker, Kathrin Schumann · 2022 · Immunology Letters
Critical cancer vulnerabilities identified by unbiased CRISPR/Cas9 screens inform on efficient cancer Immunotherapy
Margaret A. Potts, Jackson A. McDonald, Kate D Sutherland, Marco J. Herold · 2020 · European Journal of Immunology
Approaching Shared Pathophysiology in Immune-Mediated Diseases through Functional Genomics
David González‐Serna, Gonzalo Villanueva-Martín, Marialbert Acosta‐Herrera, Ana Márquez, Javier J. Martin · 2020 · Genes
Interleukin-15 cytokine checkpoints in natural killer cell anti-tumor immunity
Harrison Sudholz, Rebecca B. Delconte, Nicholas D. Huntington · 2023 · Current Opinion in Immunology
A pooled CRISPR/AsCpf1 screen using paired gRNAs to induce genomic deletions in Chinese hamster ovary cells
Valerie Schmieder, Neža Novak, Heena Dhiman, Nguyen Ngoc Ly, Evgenija Serafimova, Gerald Klanert, Martina Baumann, Helene Faustrup Kildegaard, Nicole Borth · 2021 · Biotechnology Reports
CRISPR/Cas9 genetic screens in hepatocellular carcinoma gene discovery
Cynthia H. Chiu · 2023 · Current Research in Biotechnology
UBASH3A Interacts with PTPN22 to Regulate IL2 Expression and Risk for Type 1 Diabetes
Jeremy R. B. Newman, PATRICK J. CONCANNON, Yan Ge · 2023 · International Journal of Molecular Sciences
Kinetic Measurement of Apoptosis and Immune Cell Killing Using Live-Cell Imaging and Analysis
Jill E. Granger, Daniel M. Appledorn · 2020 · Methods in molecular biology
Interfacing Biomaterials with Synthetic T Cell Immunity
Fang‐Yi Su, Quoc D. Mac, Anirudh Sivakumar, Gabriel A. Kwong · 2021 · Advanced Healthcare Materials
Single-cell heterogeneity analysis and CRISPR screens in MIN6 cell line reveal transcriptional regulators of insulin
Ruxuan Zhao, Jing Lü, Qi Li, Fengran Xiong, Yingchao Zhang, Juanjuan Zhu, Gongxin Peng, Jin‐Kui Yang · 2021 · Cell Cycle
RETRACTED ARTICLE: Deciphering cell–cell interactions and communication in the tumor microenvironment and unraveling intratumoral genetic heterogeneity via single-cell genomic sequencing
Ya-Hong Cao, Jie Ding, Qing-Hai Tang, Jie Zhang, Zhong-Yan Huang, Xiao-Mei Tang, Jibin Liu, Yu‐Shui Ma, Da Fu · 2022 · Bioengineered · Retracted
High-throughput CRISPR technology: a novel horizon for solid organ transplantation
Xiaohan Li, Zhang Chen, Weicong Ye, Jizhang Yu, Xi Zhang, Yuan Li, Yuqing Niu, Shuan Ran, Song Wang, Zilong Luo et al. · 2024 · Frontiers in Immunology
The Role of Nuclear Factor-κB in Cancer Immunity and Immunoediting
Sumon Mukherjee, Subhadip Pati, Subhanki Dhar, Tania Sarkar, Silpita Paul, Udit Basak, Sourio Chakraborty, Gaurisankar Sa · 2025 · Cancer Control
Overcoming functional and translational challenges of cellular immunotherapies for solid tumors
Yi-Ching Chen, Kok‐Siong Chen, Bruce L. Levine, Khalid Shah · 2026 · Cancer Cell
The TOP vector: a new high-titer lentiviral construct for delivery of sgRNAs and transgenes to primary T cells
Daryl G. Humes, Stephanie M. J. Rainwater, Julie M. Overbaugh · 2020 · Molecular Therapy — Methods & Clinical Development
Super‐killer CTLs are generated by single gene deletion of Bach2
Philippa R. Barton, Alexander J. Davenport, Jens L. Hukelmann, Doreen Ann Cantrell, Jane C. Stinchcombe, Arianne C. Richard, Gillian M. Griffiths · 2022 · European Journal of Immunology
How CRISPR/Cas9 Gene Editing Is Revolutionizing T Cell Research
Kristoffer Haurum Johansen · 2021 · DNA and Cell Biology
Analyzing CRISPR screens in non-conventional microbes
Varun Trivedi, Adithya Ramesh, Ian R. Wheeldon · 2023 · Journal of Industrial Microbiology & Biotechnology
Metabolic optimization of adoptive T cell transfer cancer immunotherapy: A historical overview
Donald R. Forsdyke · 2020 · Scandinavian Journal of Immunology
Translating non-coding genetic associations into a better understanding of immune-mediated disease
Christina T. Stankey, James Christopher Lee · 2023 · Disease Models & Mechanisms
Systematic identification of gene combinations to target in innate immune cells to enhance T cell activation
Lei Xia, Anastasia Komissarova, Arielle Jacover, Yehuda Shovman, Sebastian Arcila-Barrera, Sharona Tornovsky-Babeay, Milsee Mol Jaya Prakashan, Abedelmajeed Nasereddin, Inbar Plaschkes, Yuval Nevo et al. · 2023 · Nature Communications
CRISPR-based genetic screens advance cancer immunology
Yuanfang Cao, Xueting Li, Yumu Pan, Huahe Wang, Siyu Yang, Lingjuan Hong, Lupeng Ye · 2024 · Science China Life Sciences
Genetically edited CD34 + cells derived from human iPS cells in vivo but not in vitro engraft and differentiate into HIV-resistant cells
Maelig G. Morvan, Fernando Teque, Lin Ye, Mary E. Moreno, Jiaming Wang, Scott R. VandenBerg, Cheryl A. Stoddart, Yuet Wai Kan, Jay A. Levy · 2021 · Proceedings of the National Academy of Sciences
Construction and validation of a signature for T cell-positive regulators related to tumor microenvironment and heterogeneity of gastric cancer
Yangyang Guo, Yingjue Zhang, Kenan Cen, Ying Dai, Yifeng Mai, Kai Mun Hong · 2023 · Frontiers in Immunology
CRISPR in medicine: applications and challenges
Jin‐Yu Sun, Haibo Hu, Yanxiang Cheng, Xiaojie Lu · 2020 · Briefings in Functional Genomics
CRISPR tools for T cells: targeting the genome, epigenome, and transcriptome
Tassilo L A Wachsmann, Lei S. Qi · 2025 · Trends in cancer
The (re)discovery of tumor-intrinsic determinants of immune sensitivity by functional genetic screens
David W. Vredevoogd, Georgi Apriamashvili, Daniel S. Peeper · 2021 · Immuno-Oncology Technology
Tumor immune evasion: insights from CRISPR screens and future directions
Tirta Mario Djajawi, Johannes Wichmann, Stephin J. Vervoort, Conor J. Kearney · 2023 · FEBS Journal
Roles of TULA-family proteins in T cells and autoimmune diseases
Hua Wang, PATRICK J. CONCANNON, Yan Ge · 2024 · Genes and Immunity
Computational Methods for Analysis of Large-Scale CRISPR Screens
Xueqiu Lin, Augustine G. Chemparathy, Marie F. La Russa, Timothy Daley, Lei S. Qi · 2020 · Annual Review of Biomedical Data Science
Beyond Bulk Metabolomics: Emerging Technologies for Defining Cell-Type Specific Metabolic Pathways in Health and Disease
Yichen Gong, Samuel Edward Weinberg · 2025 · Biomolecules
An in vivo CRISPR screen unveils promising target genes to improve CAR-T cell efficacy in a solid tumor model
Mattia Fumagalli, Dongjie An, Luca Simula, Camille Combe, Lisa Aziez, Yannick Simoni, Marie‐Clotilde Alves‐Guerra, Andrea Valentini, Maude Marchais, Anaïs Vermare et al. · 2026 · Molecular Therapy
Dynamic chromatin architecture identifies new autoimmune-associated enhancers for IL2 and novel genes regulating CD4+ T cell activation
Matthew C. Pahl, Prabhat Kumar Sharma, Rajan M. Thomas, Zachary Thompson, Zachary Mount, James A. Pippin, Peter A. Morawski, Peng Sun, Chun Su, Daniel Campbell et al. · 2024 · eLife
Design, performance, processing, and validation of a pooled CRISPR perturbation screen for bacterial toxins
Songhai Tian, Y Qin, Yuxuan Wu, Min Dong · 2024 · Nature Protocols
Developing pioneering pharmacological strategies with CRISPR/Cas9 library screening to overcome cancer drug resistance
Yu He, Huan Li, Xueming Ju, Bo Gong · 2024 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
Intentional heterogeneity in autologous cell-based gene therapies: strategic considerations for first-in-human trials
Christopher R. Cabanski, Enjun Yang, Mark D. Stewart, Jeff D. Allen, John E Connolly, Ute Dugan, Philip D. Greenberg, Crystal Lee Mackall, Carl H. June, Alexander Marson et al. · 2025 · Journal for ImmunoTherapy of Cancer
CRISPR-Based Screening in Three-Dimensional Organoid Cultures to Identify TGF-β Pathway Regulators
Nina Frey, Gerald Schwank · 2022 · Methods in molecular biology
CRISPR screening identifies T cell-intrinsic regulators of CD3-bispecific antibody responses
Ryan D. Molony, Theresa Funk, Gina M. Trabucco, Erik Corcoran, David A. Ruddy, Malini Varadarajan, GiNell Elliot, Michelle Piquet, Joni W. Lam, Matthew J. Meyer et al. · 2022 · Frontiers in Immunology
Multiplexed transcriptomic profiling of the fate of human CAR T cells in vivo via genetic barcoding with shielded small nucleotides
Xiaoyin Lu, Shane Lofgren, Yuehui Zhao, Pawel Karol Mazur · 2023 · Nature Biomedical Engineering
Plasmid- or Ribonucleoprotein-Mediated CRISPR/Cas Gene Editing in Primary Murine T Cells
Marianne Dölz, Romina Marone, Lukas T. Jeker · 2021 · Methods in molecular biology
Turbocharging the T Cell to Fight Cancer
Andrea Schietinger · 2022 · New England Journal of Medicine
Mapping gene regulatory networks of primary CD4 + T cells using single-cell genomics and genome engineering
Rachel E. Gate, Min Cheol Kim, Andrew C. Lu, David S. Lee, Eric Shifrut, Meena Subramaniam, Alexander Marson, Chun Ye · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
In vitro and in vivo CRISPR-Cas9 screens reveal drivers of aging in neural stem cells of the brain
Tyson Ruetz, Chloe M. Kashiwagi, Bhek Morton, Robin W. Yeo, D. Leeman, D. Morgens, C. K. Tsui, Amy Li, M. Bassik, A. Brunet · 2021 · bioRxiv
Legionella pneumophila exploits the endo-lysosomal network for phagosome biogenesis by co-opting SUMOylated Rab7
Chuang Li, Jiaqi Fu, Shuai Shao, Zhao‐Qing Luo · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
A unified genetic perturbation language for human cellular programming
Austin Hartman, Oliver Takacsi-Nagy, Courtney Kernick, Nicole E. Theberath, Johnathan Lu, Lujing Wu, Michelle Mantilla, Siddhesh Mittra, Alison K. McClellan, Nicole Johnson et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
Causal circuit tracing reveals distinct computational architectures in single-cell foundation models: inhibitory dominance, biological coherence, and cross-model convergence
Ihor Kendiukhov · 2026 · Bioinformatics
Pan-cancer analysis of 60S Ribosomal Protein L7-Like 1 (RPL7L1) and validation in liver hepatocellular carcinoma
Ke‐Jie He, Guoyu Gong, E Liang, Yangbo Lv, Shuiquan Lin, Jianguang Xu · 2023 · Translational Oncology
Endogenous glucocorticoids and human immunity: Time to revisit old dogmas
Brinda Bhatt, Luis Miguel Franco · 2025 · Seminars in Immunology
Virus-like particles enable targeted gene engineering and pooled CRISPR screening in primary human myeloid cells
Hyuncheol Jung, Pascal Devant, Carter Ching, Mineto Ota, Emma Dann, Ronghui Zhu, Chandrima Modak, Ana Vasquez-Ibarra, Jennifer R. Hamilton, Zachary Steinhart et al. · 2026 · Nature Biotechnology
Large-scale compound screens and pharmacogenomic interactions in cancer
Ultan McDermott · 2019 · Current Opinion in Genetics & Development
Integrative Genomic Analysis of m6a-SNPs Identifies Potential Functional Variants Associated with Alzheimer’s Disease
Syed Mansoor Jan, Aamir Fahira, Yongyong Shi, Mohammad Imran Khan, Alam Jamal, Arif Mahmood, Sulaiman Shams, Zahida Parveen, Junjian Hu, Muhammad Umair et al. · 2023 · ACS Omega
All–potassium channel CRISPR screening reveals a lysine-specific pathway of insulin secretion
Jing Lü, Ruxuan Zhao, Fengran Xiong, Juanjuan Zhu, Tingting Shi, Yingchao Zhang, Gongxin Peng, Jin‐Kui Yang · 2024 · Molecular Metabolism
CRISPR/Cas9 Technology for Modifying Immune Checkpoint in CAR-T Cell Therapy for Hematopoietic Malignancies
Forough Shams, Elham Sharif, Hajar Abbasi‐Kenarsari, Nader Hashemi, Masoumeh Sadat Hosseini, Neda Heidari, Effat Noori, Ali Hossein Amini, Maryam Bazrgar, Maryam Rouhani et al. · 2025 · Current Gene Therapy
Methods to edit T cells for cancer immunotherapy
Francesca Lucibello, Silvia Menegatti, Laurie Menger · 2019 · Methods in enzymology on CD-ROM/Methods in enzymology
Computation of Transcriptional Networks of Circulating Immune Cells in Type 1 Diabetes
Scott A. Ochsner, Rudolf Pillich, Deepali Rawool, Jeffrey S. Grethe, Neil J. McKenna · 2022 · iScience
Improving Cancer Immunotherapy with CRISPR‐Based Technology
Zexu Li, Fei Teng · 2020 · Advanced Biosystems
Bioinformatic Approaches to Validation and Functional Analysis of 3D Lung Cancer Models
P. Jonathan Li, Jeroen P. Roose, David M. Jablons, Johannes Ruediger Kratz · 2021 · Cancers
A rapid CRISPR competitive assay for in vitro and in vivo discovery of potential drug targets affecting the hematopoietic system
Yunbing Shen, Long Jiang, Vaishnavi Srinivasan Iyer, Bruno Raposo, Anatoly P. Dubnovitsky, Sanjaykumar V. Boddul, Zsolt Kasza, Fredrik Wermeling · 2021 · Computational and Structural Biotechnology Journal
CRISPR/Cas9-Based Genetic Screening to Study T-Cell Function
Wanjing Shang, Fei Wang, Qi Zhu, Liangyu Wang, Haopeng Wang · 2020 · Methods in molecular biology
Potentiating the anti-tumor response of tumor infiltrated T cells by NAD + supplementation
Yuetong Wang, Fei Wang, Lihua Wang, Shizhen Qiu, Yufeng Yao, Xuexue Xiong, Xuyong Chen, Quanquan Ji, Jian Cao, Dake Li et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
Joint single-cell measurements of surface proteins, intracellular proteins and gene expression with icCITE-seq
Kelvin Y. Chen, Yusuke Takeshima, André Luiz Zorzetto-Fernandes, Kenichi Makino, Tatsuya Kibayashi, Mayu Hata, Kenji Ichiyama, Joshua D. Croteau, Kevin Taylor, Shimon Sakaguchi · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
Genome Engineering for Next-Generation Cellular Immunotherapies
Jonathan Joon-Young Park, Kyoung A. Viola Lee, Stanley Z. Lam, Kaiyuan Tang, Sidi Chen · 2022 · Biochemistry
Genome editing or small molecule inhibition of KMT5A in CAR-T cells enhances antitumor immunity
Xiaoling Tian, Guolong Liu, Qiudao Wang, Na Zhang, Yanting Shen, Bing Du, Yuxuan Wu · 2025 · Journal for ImmunoTherapy of Cancer
CAR-T cell therapy: A therapeutic strategy for cancer treatment
Shabana Sharif, Upma Sharma, Ashok Kumar Yadav · 2025 · Seminars in Oncology
ADA1-Driven Metabolic Refueling Enhances CAR T Cell Therapy for Solid Tumors
Alex Wade Song, Xiao‐Tong Song · 2025 · Cancers
Rewriting the epigenome: CRISPR tools for biological discovery and therapeutics
Christian Otero, Lei S. Qi · 2026 · Current Opinion in Biomedical Engineering
Systematic discovery of pro- and anti-HIV host factors in primary human CD4+ T cells
Ujjwal Rathore, Eli J. Dugan, Hunter Thornton, Vigneshwari Easwar Kumar, Rama Dajani, Ryan C. Burdick, Janet M. Young, Zachary Steinhart, Reanna Lao, Krista A. Delviks‐Frankenberry et al. · 2026 · Cell
Repurposing base editors for targeted knockin and simultaneous multiplex knockouts to generate allo-CAR T cells with minimal translocations
Viktor Glaser, Becker. Lily Jo, Carla Fuster‐García, Eric J. Aird, Luis Huth, Ana-Maria Nitulescu, Yaolin Pu, Isabell Kassing, Laura Marie Hartmann, Christian Luca Flugel et al. · 2026 · Molecular Therapy
Pooled screening with next-generation gene editing tools
Liqun Zhou, Luojia Yang, Yanzhi Feng, Sidi Chen · 2023 · Current Opinion in Biomedical Engineering
Finding a needle in a haystack: functional screening for novel targets in cancer immunology and immunotherapies
Yi Du, Yang Yang, Bohao Zheng, Qian Zhang, Shengtao Zhou, Linjie Zhao · 2025 · Oncogene
High-throughput CRISPR approaches: New solutions for challenging problems
Gargi Bindal, Chitra Seetharam Misra, Mandeep Kumar Singh, Shyam Sunder Rangu, Neha Pandey, Devashish Rath · 2025 · TrAC Trends in Analytical Chemistry
Listening in on Multicellular Communication in Human Tissue Immunology
Julian J. Albers, Karin Pelka · 2022 · Frontiers in Immunology
Bourgeoning Cancer Targets
Priyanka Kriplani · 2022 · Recent Patents on Anti-Cancer Drug Discovery
Exploring new frontiers in prostate cancer research: Report from the 2022 Coffey−Holden prostate cancer academy meeting
Andrea K. Miyahira, Jessica E. Hawley, Remi M. Adelaiye-Ogala, Jérémie Calais, Lucia Nappi, Ravi Bharat Parikh, Tyler M. Seibert, Elizabeth V. Wasmuth, Xiao X. Wei, Kenneth J. Pienta et al. · 2022 · The Prostate
The CRISPR System and Cancer Immunotherapy Biomarkers
Vitaly Balan, Jianbin Wang · 2019 · Methods in molecular biology
Transcription factor collaboration enables precise T cell state engineering
Rachel E. Savage, Christian D. McRoberts Amador, Conrad Hock, Ruochi Zhang, Hung‐Che Kuo, Aretha Gao, Max A. Horlbeck, Charles A. Gersbach, Jason Daniel Buenrostro · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
Single‐Cell CRISPR: An Efficient Strategy for Decoding Plant Cis ‐Regulatory Complexity
Yuanhang Zhang, Xuanxuan Luo, Hongbin Li, Shuangxia Jin, Xianlong Zhang, Yuzheng Wang · 2026 · Plant Biotechnology Journal
Genome-wide CRISPR screens in primary human natural killer cells identify countermeasures against immunosuppressive environment
Quoc Viet Nguyen, Yi-Jun Lan, Jason Cheng-Yu Chang, Hsin-An Shih, Jenifer Faustine, Cheng-Chieh Chen, Shu-Yu Ho, Ching-Wen Cheng, Tsu-Lan Chao, Steven Lin · 2026 · Nature Communications
CAR T-Cell Therapy in Solid Tumors: Current Review and Future Perspectives
Jiaxuan Zheng · 2023 · Highlights in Science Engineering and Technology
Optimized minimal genome-wide human sgRNA library
Yangfan Zhou, Lixia Wang, Zhike Lu, Zhenxing Yu, Lijia Ma · 2023 · Scientific Reports
Development of iPSC-derived T cells targeting EGFR neoantigens in non-small cell lung cancer
Kouta Niizuma, Toshinobu Nishimura, Jonathan Villanueva, Laura Amaya, Jonas L. Fowler, Taichi Isobe, Yusuke Nakauchi, Brandon Saavedra, Haojun Xu, Mahito Nakanishi et al. · 2025 · Molecular Therapy — Methods & Clinical Development
BLIMP-1 and CEACAM1 cooperatively regulate human Treg homeostasis and function to control xenogeneic GVHD
Ying Ding, Aixin Yu, Miloš Vujanac, Sabrina N. Copsel, Alejandro Moro, Luis Alberto Nivelo, Molly Dalzell, Nicolas Tchitchek, Michèlle Rosenzwajg, Alejandro V. Villarino et al. · 2025 · JCI Insight
FCRL3 is an immunoregulatory receptor that restrains the activation of human memory T lymphocytes
Niccolò Bianchi, Elena Foli, Mehrpouya Mostanfar, Roberta Marzi, Mara Cetty Spinella, Sara Polletti, Matteo Pecoraro, Antonino Cassotta, Roshan Singh Thakur, David Jarrossay et al. · 2025 · The Journal of Experimental Medicine
Overcoming lentiviral delivery limitations in hard-to-transduce suspension cells for genome-wide CRISPR screening
Antonino Napoleone, Ivy Rose Sebastian, Federico De Marco, Alexander Molin, Mohamed Hussein, Lovro Kramer, Thomas Jostock, Thomas Kelly, Nicole Borth · 2026 · Molecular Therapy Advances
Editing of Endogenous Genes in Cellular Immunotherapies
Theodore L. Roth · 2020 · Current Hematologic Malignancy Reports
Rapid and efficient generation of antigen‐specific isogenic T cells from cryopreserved blood samples
Anneke L. Eerkens, Annegé Vledder, Nienke van Rooij, Floris Foijer, Hans W. Nijman, Marco de Bruyn · 2022 · Immunology and Cell Biology
Adding a Chemical Biology Twist to CRISPR Screening
Shiying Huang, Jeremy M. Baskin · 2022 · Israel Journal of Chemistry
Macrobrachium rosenbergii Genome Editing Breeding with CRISPR–Cas Nucleases, Base Editors, and Prime Editors
Guo Li, Xinzhi Zhou, Guanglin Zhu, Yingjia Pan, Junjun Yan, Jilun Meng, Tiantian Ye, Yaxian Cheng, Cui Liu, Zhimin Gu · 2025 · Animals
Erythrocyte–Plasmodium interactions: genetic manipulation of the erythroid lineage
Marilou Tétard, Nana Ansuah Peterson, Elizabeth S. Egan · 2022 · Current Opinion in Microbiology
Advanced genomics and clinical phenotypes in psoriatic arthritis
Matteo L. Vecellio, Stefano Rodolfi, Carlo Francesco Selmi · 2021 · Seminars in Immunology
CRISPR technology for immuno-oncology applications
Jianbin Wang, Vitaly Balan, Francesco Maria Marincola · 2019 · Methods in enzymology on CD-ROM/Methods in enzymology